Previous 10 | Next 10 |
WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and develop...
Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market Canada NewsWire Inotiv offers fit-for-purpose drug testing ...
Inotiv, Inc. (NOTV) Q1 2023 Earnings Conference Call February 13, 2023 4:30 PM ET Company Participants Devin Sullivan - The Equity Group Inc. Bob Leasure - President and Chief Executive Officer Beth Taylor - Senior Vice President and Chief Financial Officer Confe...
Inotiv press release ( NASDAQ: NOTV ): FQ1 GAAP EPS of -$3.41 misses by $1.87 . Revenue of $122.8M (+45.8% Y/Y) misses by $3.78M . For FY 2023, co confirms guidance of at least $580M of revenue. The consensus revenue estimate is $575.08M. For further details ...
WEST LAFAYETTE, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The Headwaters Capital portfolio gained +7.2% in Q4 ’22 compared to a +9.2% gain for the Russell Mid Cap Index. My outlook remains la...
WEST LAFAYETTE, Ind., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
WEST LAFAYETTE, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
WEST LAFAYETTE, Ind., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm...
INOTIV INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inotiv, Inc. - NOTV INOTIV INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Di...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...